Related Experiment Video
Updated: Aug 12, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Meningococcal meningitis group A: a successful control of an outbreak by mass vaccination
H E Bushra1, M Y Mawlawi, R E Fontaine
1Department of Preventive Medicine, Ministry of Health, Riyadh, Saudi Arabia.
Abstract:
Jeddah is the main point of entry to the holy places in Saudi Arabia. An outbreak of meningococcal disease (MCD) occurred during the fasting lunar month for Muslims, Ramadan (March-April) of 1992. To assess the threat of local spread of MCD within Jeddah, the effects of previous and a mass vaccination programme against MCD during the outbreak, we reviewed the medical records of confirmed cases (CC) of MCD (defined as a bacteriologically confirmed case or a case diagnosed by latex test) and their vaccination status in the last five years before the outbreak. There were 41 CC of meningitis due to Neisseria meningitidis (group A). The ratio of males to females was 4.1:1. Thirty two percent of the cases were religious visitors. About one fourth (22%) of the cases were Pakistani. More than half (57%) of the cases, who were residents of Jeddah, lived in the north-eastern part of the city, as did half of the Pakistani cases. The case-fatality rate among CC was 19.5%. Persons who visited the Makkah (Mecca) during Ramadan were more likely to get the disease than those who did not (odds ratio [OR] = 6.1; 95% confidence interval [CI] 1.4-40.7). Unvaccinated persons were more likely to get the disease than those who were vaccinated against MCD (OR = 13.9; 95% CI 1.8-296). Meningococcal vaccine (MCV) against MCD was effective in preventing the disease. However, MCV was of no protective value if it had been administered more than five years before the outbreak. The reason mentioned most frequently for not being vaccinated by both cases (84%) and controls (57%) was lack of knowledge about the disease. Health education programmes should be strengthened and promoted. A good collaborative surveillance system between Jeddah and other holy cities, especially Makkah, is needed to abort outbreaks among religious visitors and to prevent the spread of MCD outbreaks.
Insights
Meningococcal disease (MCD) outbreaks can be prevented with timely vaccination. Meningococcal vaccine (MCV) is effective, but protection wanes after five years. Health education and surveillance are crucial for controlling MCD spread.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Jeddah, Saudi Arabia, serves as a primary entry point for pilgrims visiting holy sites.
- An outbreak of meningococcal disease (MCD) occurred in Jeddah during Ramadan 1992.
- Assessing the spread and control of MCD is vital, especially concerning religious visitors.
Purpose of the Study:
- To evaluate the impact of prior and mass vaccination programs on MCD spread in Jeddah.
- To analyze risk factors associated with MCD during the 1992 outbreak.
- To determine the effectiveness and duration of protection offered by meningococcal vaccine (MCV).
Main Methods:
- Retrospective review of medical records for confirmed MCD cases (1987-1992).
- Analysis of case-fatality rates, vaccination status, and demographic data.
- Comparison of risk between vaccinated and unvaccinated individuals, and those visiting Makkah.
Main Results:
- Forty-one confirmed cases of Neisseria meningitidis (group A) meningitis were identified.
- The case-fatality rate was 19.5%. Religious visitors and unvaccinated individuals faced higher risks.
- MCV was effective, but protection diminished if administered over five years prior to the outbreak.
Conclusions:
- Meningococcal vaccine (MCV) is effective but requires timely administration for optimal protection.
- Lack of knowledge about MCD is a significant barrier to vaccination.
- Enhanced health education and robust surveillance systems are essential to prevent and control MCD outbreaks, particularly among religious visitors.
More Related Videos
Related Concept Videos
Vaccinations
Bacterial Meningitis
Smallpox
Viral Meningitis
Poliomyelitis
Bacterial Meningitis I: Introduction

